These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34389303)

  • 1. Progression to Transplant Under the New Heart Allocation System: The Society of Thoracic Surgeons Intermacs Database.
    Yarboro LT; Mehaffey JH; Cantor R; Deng L; Teman NR; Yount KW; Kern JA; Kirklin JK; Bergin JD
    Ann Thorac Surg; 2022 Jun; 113(6):1926-1934. PubMed ID: 34389303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers.
    Cascino TM; McCullough JS; Wu X; Pienta MJ; Stewart JW; Hawkins RB; Brescia AA; Abou El Ala A; Zhang M; Noly PE; Haft JW; Cowger JA; Colvin M; Aaronson KD; Pagani FD; Likosky DS;
    JAMA Netw Open; 2022 Nov; 5(11):e2240646. PubMed ID: 36342716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
    Mullan CW; Chouairi F; Sen S; Mori M; Clark KAA; Reinhardt SW; Miller PE; Fuery MA; Jacoby D; Maulion C; Anwer M; Geirsson A; Mulligan D; Formica R; Rogers JG; Desai NR; Ahmad T
    JACC Heart Fail; 2021 Jun; 9(6):420-429. PubMed ID: 33714748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Strategy Between Bridge to Transplant and Destination LVAD Therapy After the First 3 Months: Analysis of the STS-INTERMACS Database.
    Rali AS; Inampudi C; Zalawadiya S; Shah A; Teuteberg JJ; Stewart GC; Cantor RS; Deng L; Jacobs JP; Kirklin JK; Stevenson LW
    J Card Fail; 2024 Apr; 30(4):552-561. PubMed ID: 37898382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Society of Thoracic Surgeons Intermacs 2022 Annual Report: Focus on the 2018 Heart Transplant Allocation System.
    Yuzefpolskaya M; Schroeder SE; Houston BA; Robinson MR; Gosev I; Reyentovich A; Koehl D; Cantor R; Jorde UP; Kirklin JK; Pagani FD; D'Alessandro DA
    Ann Thorac Surg; 2023 Feb; 115(2):311-327. PubMed ID: 36462544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
    Uriel MH; Clerkin KJ; Takeda K; Naka Y; Sayer GT; Uriel N; Topkara VK
    J Heart Lung Transplant; 2023 Jan; 42(1):124-133. PubMed ID: 36272893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes of left ventricular assist device recipients transplanted before and after the new donor heart allocation system.
    Doulamis IP; Inampudi C; Kourek C; Mandarada T; Kuno T; Asleh R; Briasoulis A
    Artif Organs; 2022 Dec; 46(12):2460-2468. PubMed ID: 35841284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable left ventricular assist device support as a bridge to heart transplant candidacy†.
    Shaw SM; Venkateswaran R; Hogg R; Rushton S; Al-Attar N; Schueler S; Lim S; Parameshwar J; Banner NR
    Interact Cardiovasc Thorac Surg; 2019 Apr; 28(4):594-601. PubMed ID: 30351360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device.
    Jawitz OK; Fudim M; Raman V; Blumer V; Caliskan K; DeVore AD; Mentz RJ; Milano C; Soliman O; Rogers J; Patel CB
    Ann Thorac Surg; 2020 Aug; 110(2):567-574. PubMed ID: 31904371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable left ventricular assist devices as a bridge to transplantation: what to expect along the way?
    Fernandez Valledor A; Moeller CM; Rubinstein G; Oren D; Rahman S; Baranowska J; Lee C; Lorenzatti D; Righini FM; Lotan D; Sayer GT; Uriel N
    Expert Rev Med Devices; 2024 Sep; 21(9):829-840. PubMed ID: 39169616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Teuteberg JJ; Stewart GC; Jessup M; Kormos RL; Sun B; Frazier OH; Naftel DC; Stevenson LW
    JACC Heart Fail; 2013 Oct; 1(5):369-78. PubMed ID: 24621968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World".
    Fernandez Valledor A; Rubinstein G; Moeller CM; Lorenzatti D; Rahman S; Lee C; Oren D; Farrero M; Sayer GT; Uriel N
    J Heart Lung Transplant; 2024 Jun; 43(6):1010-1020. PubMed ID: 38360159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation.
    Okoh AK; Selevanny M; Singh S; Hirji S; Singh S; Al Obaidi N; Lee LY; Camacho M; Russo MJ
    ESC Heart Fail; 2020 Oct; 7(5):2744-2751. PubMed ID: 32627939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased frequency of transplantation and lower post-transplant survival free of re-transplantation in LVAD patients with the new heart transplant allocation system.
    Jani M; Lee S; Acharya D; Hoeksema S; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2022 Jan; 36(1):e14493. PubMed ID: 34689383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries.
    Michel E; Orozco Hernandez E; Enter D; Monge M; Nakano J; Rich J; Anderson A; Backer C; McCarthy P; Pham D
    Artif Organs; 2019 Jan; 43(1):90-96. PubMed ID: 30129258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.